TEVA's quarterly CC on the 4th. If TEVA doesn't give an update on the epipen then I imagine ATRS will do the same. Its inexcusable for ATRS to not be able to update their shareholders on this program.
>>AMAG Pharmaceuticals to Host Conference Call on August 9, 2016 at 8:00 a.m. ET to Discuss Financial Results for the Second Quarter Ended June 30, 2016